Comparing Acupuncture With Medication to Reduce Depression, Anxiety and Comorbid Sleep Disorders in China
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18-65
SponsorDuke Kunshan University
About this trial
The main objective of this study is to compare medication (usual care; active comparator) with acupuncture (as experimental intervention) to identify the most (cost)effective and environmentally sustainable intervention to reduce depression, anxiety and comorbid sleep disorders in adults (18-65) in China.
Eligibility criteria
Qualifiers
Chinese nationals 18-65 years old
Depressive state: Depression Self-Rating Scale (SDS) raw score ≥43; standard score ≥53 (27)
Anxiety state: Anxiety Self-Rating Scale (SAS) raw score ≥40; standard score ≥50 (28) Note: (standard score = raw score X 1.25)
Disqualifiers
Patients with severe comorbid physical illnesses that prevent them from completing the full course of treatment;
Patients with a risk of suicide;
Patients with a history of head trauma, loss of consciousness, or severe mental disorders;
Patients with drugs or alcohol abuse;
Trial design
Treatments tested in this trial
- Psychotropic Drugs
- Acupuncture
Treatment groups
180 Participants
are divided into 2 treatment groupsSponsors and collaborators
Duke Kunshan University
Lead sponsor
Kunshan Hospital of Traditional Chinese Medicine
Collaborator
Kunshan Mental Health Center
Collaborator
National Natural Science Foundation of China
Collaborator
Source ClinicalTrials.gov